A racemic mixture of acetyl-D-carnitine and acetyl-L-carnitine
Related Products
Isomer(s)
16948Acetyl-L-carnitine (chloride)
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Acetyl-DL-carnitine (chloride)

Item No. 31015

Product Insert (PDF)Safety Data Sheet (SDS) (PDF)
Technical Information
Formal Name
2-(acetyloxy)-3-carboxy-N,N,N-trimethyl-1-propanaminium, monochloride
CAS Number
2504-11-2
Synonyms
  • (±)-Acetylcarnitine
  • DL-Acetylcarnitine
  • CAR 2:0
  • C2:0 Carnitine
  • DL-Carnitine acetyl ester
Molecular Formula
C9H18NO4 • Cl
Formula Weight
239.7
Purity
≥98%
Formulation (Request formulation change)
A solid
Solubility(Learn about Variance in Solubility)
Acetonitrile: Slightly SolubleMethanol: SolubleWater: Soluble
SMILES
OC(CC(OC(C)=O)C[N+](C)(C)C)=O.[Cl-]
InChi Code
InChI=1S/C9H17NO4.ClH/c1-7(11)14-8(5-9(12)13)6-10(2,3)4;/h8H,5-6H2,1-4H3;1H
InChi Key
JATPLOXBFFRHDN-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Wet ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Download most recent Certificate of Analysis for this product

    50 mg

    $50

    Add

    100 mg

    $80

    Add

    250 mg

    $174

    Add

    500 mg

    $323

    Add
    Lipid Resource Center
    Discover Products & Resources for Lipid Research
    • High-purity lipid standards
    • Lipid roles in biology
    • Lipids in health & disease
    • Lipids for pharmaceutical development
    • Protocols, advice, & resources
    EXPLORE NOW
    Product Description

    Acetyl-DL-carnitine is a racemic mixture of the short-chain acylcarnitine acetyl-D-carnitine and the mitochondrial metabolite acetyl-L-carnitine (Item No. 16948). It increases the oxidation rate of the branched-chain 2-oxo acid 3-methyl-2-butanoate in isolated rat muscle mitochondria in the absence of carnitine when used at a concentration of 1 mM.1 Acetyl-DL-carnitine decreases the hind limb vasculature blood flow rate in rats in a dose-dependent manner.2 It decreases the levels of palmitic acid (Item No. 10006627) and oleic acid (Item Nos. 90260 | 24659) in the cerebral cortex during the recovery period in a dog model of hypoglycemic brain injury induced by insulin.3

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Veerkamp, J.H., van Moerkerk, H.T.B., and Wagenmakers, A.J.M. Interaction of short-chain and branched-chain fatty acids and their carnitine and CoA esters and of various metabolites and agents with branced-chain 2-oxo acid oxidation in rat muscle and liver mitochondria. Int. J. Biochem. 17(9), 967-974 (1985).

    2. Louis-Ferdinand, R.T., Cutroneo, K.R., Kosegarten, D.C., et al. Flow decrease through rat hind limb vasculature by (plus or minus)-carnitine, (plus or minus)-acetylcarnitine and (plus or minss)-chloroacetylcarnitine chlorides. J. Pharm. Pharmacol. 22(9), 704-705 (1970).

    3. Benzi, G., Gorini, A., Dossena, M., et al. Recovery after hypoglycemic brain injury. Action of some biological substances on the cerebral metabolism. Biochem. Pharmacol. 32(6), 1083-1091 (1983).